Severe pulmonary toxicity following azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease: a case series

被引：0
|
作者：
Ananthakrishran, AN
Atilla, T
Bajaj, JS
Otterson, MF
Lipchick, R
Massey, BT
Maloney, J
Komorowski, R
Binion, DG
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A575 / A575
页数：1
相关论文
共 50 条
  • [31] The Efficacy of Low Dose Azathioprine/6-mercaptopurine in Patients with Inflammatory Bowel Disease
    Kim, Dong Uk
    Kim, Young-Ho
    Kim, Beom Jin
    Chang, Dong Kyung
    Son, Hee Jung
    Rhee, Poong-Lyul
    Kim, Jae J.
    Rhee, Jong Chul
    HEPATO-GASTROENTEROLOGY, 2009, 56 (94-95) : 1395 - 1402
  • [32] The effects of azathioprine or 6-mercaptopurine on birth outcome in women with inflammatory bowel disease
    Shim, L. S. E.
    Simring, A. A.
    Eslick, G. D.
    Murray, H.
    Weltman, M. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A182 - A182
  • [33] Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease
    Mottet, Christian
    Schoepfer, Alain M.
    Juillerat, Pascal
    Cosnes, Jacques
    Froehlich, Florian
    Kessler-Brondolo, Vera
    Seibold, Frank
    Rogler, Gerhard
    Vavricka, Stephan R.
    Michetti, Pierre
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (11) : 2733 - 2747
  • [34] 6-Mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine
    Domènech, E
    Nos, P
    Papo, M
    López-San Roman, A
    Garcia-Planella, E
    Gassull, MA
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (01) : 52 - 55
  • [35] Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease
    Kader, HA
    Wenner, WJ
    Telega, GW
    Maller, ES
    Baldassano, RN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 30 (04) : 409 - 413
  • [36] Genetic damage to sperm following treatment with azathioprine/6-mercaptopurine (AZA/6MP) in men with inflammatory bowel disease (IBD)
    Mahadevan, Uma
    Velayos, Fernando
    Corley, Douglas A.
    Idomsky, Yelena
    Evenson, Donald
    Turek, Paul
    GASTROENTEROLOGY, 2007, 132 (04) : A52 - A52
  • [37] Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy
    Cuffari, C
    Hunt, S
    Bayless, TM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) : 1009 - 1014
  • [38] EFFICACY OF 6-MERCAPTOPURINE IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    HINOJOSA, J
    MOLES, JR
    NOS, P
    HOYOS, M
    RAMIREZ, JJ
    PRIMO, J
    FERNANDEZ, J
    BERENGUER, JY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1995, 87 (11) : 775 - 780
  • [39] Azathioprine and 6-mercaptopurine use for inflammatory bowel disease is associated with an increased risk of lymphoma
    Kandiel, AE
    Fraser, AJ
    Korelitz, BI
    Brensinger, CM
    Lewis, JD
    GASTROENTEROLOGY, 2004, 126 (04) : A19 - A19
  • [40] The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy
    Boulton-Jones, JR
    Pritchard, K
    Mahmoud, AA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) : 1561 - 1565
12345